Table 5.
The Adverse Events Due to the Administration of SGLT2 Inhibitors in 132 Patients.
Total | 13 cases |
Systemic eruption | 1 case |
Cystitis | 2 cases |
Pudendal pruritus | 2 cases |
Nausea | 1 case |
Malaise | 1 case |
Strong sense of hunger | 1 case |
Non-severe hypoglycemia | 5 cases |